基本資料
種類: ETF
費用比率%: 0.54
資產淨值: 44.88
成立日期: 30/10/2024
 
分析
市值分佈:
72.87%
大市值
25.04%
中市值
3.26%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 14/11/2026 05:08) 總持有投資項目: 38  
0%
 
100%
     10大 (55.34%)
代號 名稱 佔比% ▼ 持有日期
REPLReplimune Group9.0130/10/2026
LIVNLivaNova PLC6.8730/10/2026
COGTCogent Biosciences6.0330/10/2026
TVTXTravere Therapeutics5.8330/10/2026
GHGuardant Health5.5730/10/2026
BLLNBilliontoone Inc5.0630/10/2026
CORTCorcept Therapeutics4.6230/10/2026
MANEVeradermics Inc4.2730/10/2026
SYRESpyre Therapeutics4.1130/10/2026
UTHRUnited Therapeutics Corp3.9730/10/2026
MIRMMirum Pharmaceuticals3.4830/10/2026
CYTKCytokinetics3.2630/10/2026
ICUIICU Medical2.7530/10/2026
AXSMAxsome Therapeutics2.7430/10/2026
TMDXTransMedics Group2.7330/10/2026
SVRASavara2.7030/10/2026
NKTRNektar Therapeutics2.6030/09/2026
TWSTTwist Bioscience Corp2.3430/10/2026
DNTHDianthus Therapeutics2.3230/09/2026
TRVITrevi Therapeutics2.2230/10/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.